Assignee
NEXMOS CO LTD
KR·4 granted patents·4 pending applications·7 citations·filing 2016–2021
Top patents by PatentIndex Score
8 records- 0180US10201489B2Method for preventing spontaneous oxidation of antioxidant using aptamer, aptamer-based control of the release rate of active ingredient in the hydrogel, material and use thereofNEXMOS CO LTD·Filed 2017·Granted Feb 12, 2019·4 cites·2 claims
- 0277US10655131B2Aptamer specifically binding to L-Ascorbic acid and use of the sameNEXMOS CO LTD·Filed 2018·Granted May 19, 2020·3 cites·4 claims
- 0357US12227747B2Composition comprising aptamer as active ingredient for treatment and prevention of degenerative brain diseaseNEXMOS CO LTD·Filed 2019·Granted Feb 18, 2025·0 cites·5 claims
- 0456US2022002728A1Method for preventing oxidation of polyphenol by means of aptamer, material thereof, and use thereofNEXMOS CO LTD·Filed 2019·Application pending·0 cites
- 0553US12570984B2DNA aptamer specifically binding to glutathione and use thereofNEXMOS CO LTD·Filed 2021·Granted Mar 10, 2026·0 cites·2 claims
- 0640US2021332363A1Blood-brain barrier permeable aptamer and application thereofNEXMOS CO LTD·Filed 2019·Application pending·0 cites
- 0737US2020054256A1Method for fabricating microneedle-based diagnostic skin patch coated with aptamer and patchNEXMOS CO LTD·Filed 2019·Application pending·0 cites
- 0833US2019328938A1Method for fabricating microneedle-based diagnostic skin patch coated with aptamer and patchNEXMOS CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEXMOS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →